Exenatide(Exenatide) Pen,Disposable


Combined with:

Metformin Hcl

Indications and Reactions:

Role Indications Reactions
Primary
Type 2 Diabetes Mellitus 89.6%
Drug Use For Unknown Indication 2.6%
Insulin-requiring Type 2 Diabetes Mellitus 2.3%
Insulin-requiring Type Ii Diabetes Mellitus 1.7%
Insulin Resistance 1.4%
Diabetes Mellitus 0.9%
Type 1 Diabetes Mellitus 0.6%
Weight Decreased 0.6%
Weight Control 0.3%
Weight Decreased 61.5%
Nausea 10.2%
Weight Increased 6.9%
Vomiting 5.3%
Blood Glucose Increased 2.3%
Weight Fluctuation 1.6%
Drug Exposure During Pregnancy 1.3%
Drug Ineffective 1.3%
Tremor 1.3%
Drug Effect Decreased 1.0%
Nervousness 1.0%
Somnolence 1.0%
Injection Site Bruising 0.7%
Injection Site Pruritus 0.7%
Malaise 0.7%
Regurgitation 0.7%
Stomach Discomfort 0.7%
Stress 0.7%
Urticaria 0.7%
Vision Blurred 0.7%
Secondary
Type 2 Diabetes Mellitus 92.8%
Insulin-requiring Type 2 Diabetes Mellitus 2.3%
Insulin-requiring Type Ii Diabetes Mellitus 1.4%
Type 1 Diabetes Mellitus 1.4%
Drug Use For Unknown Indication 0.9%
Insulin Resistance 0.9%
Diabetes Mellitus 0.5%
Weight Decreased 65.6%
Weight Increased 9.1%
Nausea 7.2%
Weight Fluctuation 3.3%
Vomiting 2.9%
Blood Glucose Increased 1.9%
Drug Effect Decreased 1.9%
Injection Site Extravasation 1.4%
Injection Site Pruritus 1.0%
Nervousness 1.0%
Drug Ineffective 0.5%
Faeces Hard 0.5%
Incorrect Dose Administered 0.5%
Injection Site Bruising 0.5%
Injection Site Haemorrhage 0.5%
Injection Site Pain 0.5%
Injection Site Urticaria 0.5%
Palpitations 0.5%
Pneumonia 0.5%
Regurgitation 0.5%

Drug Data